Net income
-158 million USD
2025-10-01 – 2026-09-30
Market value
$317.69M
63,221,970 shares as of 2026-11-06, at $5.025 a share (KYTX, IEX close on 2026-11-12) Primary-source evidence
20 filing records in this dataset, filed from 2024-01-16 to 2026-11-12. Reported financial figures are available; chart coverage varies by period.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
Window: transactions dated on or after 2025-11-18.
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
31818000 USD
62537376 shares
42.80% · 18.7 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
-158 million USD
2025-10-01 – 2026-09-30
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-11-12.
Financial data available through: 2025-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
−USD 127.48 million
–
Current period
−USD 161.31 million
–
-161307000 − -127477000 = -33830000 USD
-127477000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-161307000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 114.3 million
–
Current period
−USD 153.7 million
–
-153700000 − -114300000 = -39400000 USD
-114300000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-153700000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 2.21 million
–
Current period
USD 5,000
–
5000 − 2205000 = -2200000 USD
2205000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source5000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value | Source evidence |
|---|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|
Cash generated by the company’s normal business operations.
| Period | Series | Value | Source evidence |
|---|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2023 2023-01-01 – 2023-12-31 | −USD 60.37 million Exact valueExact value: -60366000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 52.4 million Exact valueExact value: -52400000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 621,000 Exact valueExact value: 621000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 53.02 million Calculation and evidence-52400000 − 621000 USD Exact free cash flow: -53021000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2024-01-01 – 2024-12-31 | −USD 127.48 million Exact valueExact value: -127477000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 114.3 million Exact valueExact value: -114300000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 2.21 million Exact valueExact value: 2205000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 116.51 million Calculation and evidence-114300000 − 2205000 USD Exact free cash flow: -116505000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2025-01-01 – 2025-12-31 | −USD 161.31 million Exact valueExact value: -161307000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 153.7 million Exact valueExact value: -153700000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 5,000 Exact valueExact value: 5000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 153.71 million Calculation and evidence-153700000 − 5000 USD Exact free cash flow: -153705000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
20 filings · 766 latest values · 766 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001994702, 1994702, KYTX, edgar:1994702
Also known as Kyverna Therapeutics, Inc.